Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism

Journal of General Virology

Volumn 78, Issue 3, 1997, Pages 611-618

  Willett, Brian ^a   Hosie, Margaret ^a   Shaw, Andrew ^b   Neil, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

EID: 0031051160     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-3-611     Document Type: Article

References (47)

1. Arthos, J., Deen, K. C., Chaikin, M. A., Fornwald, J. A., Sathe, G., Sattentau, Q. J., Clapham, P. R., Weiss, R. A., McDougal, J. S., Pietropaolo, C, Axel, R., Truneh, A., Maddon, P. J. & Sweet, R. W. (1989). Identification of the residues in human CD4 critical for the binding of HIV. Cell 57, 469-481.
2. Arthos, J., Deen, K. C., Chaiken, M. A., Sattentau, Q. J., Maddon, P. J., Axel, R., Rosenberg, M., Shatzman, A., Truneh, A. & Sweet, R. W. (1990). Structural analysis of the HIV gp120 binding domain of the CD4 receptor. Aids Research and Human Retroviruses 6, 118.
3. Arthur, L. O., Bess, J. W. J., Sowder, R. C., Benveniste, R. E., Mann, D. L., Chermann, J. C. & Henderson, L. E. (1992). Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258, 1935-1938.
4. Arthur, L. O., Bess, J. W., Urban, R. G., Strominger, J. L., Morton, W. R., Mann, D. L., Henderson, L. E. & Benveniste, R. E. (1995). Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. Journal of Virology 69, 3117-3124.
5. Benkirane, M., Corbeau, P., Housset, V. & Devaux, C. (1993). An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO Journal 12, 4909-4921.
6. Braun, J. M. A., Gras, G., Chapuis, F., Sommerfelt, M. A., Clapham, P. R., Weiss, R. A., Åsjo, B., Gluckman, J.-C., Dormont, D. & Barré-Sinoussi, F. (1995). In Leucocyte Typing V, pp. 465-468. Edited by S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein T. Springer, T. F. Tedder & R. F. Todd. Oxford: Oxford University Press.
7. Briant, L., Benkirane, M., Girard, M., Hirn, M., Iosef, C. & Devaux, C. (1996). Inhibition of human immunodeficiency virus type 1 production in infected peripheral blood mononuclear cells by human leukocyte antigen class I-specific antibodies: evidence for a novel antiviral mechanism. Journal of Virology 70, 5213-5220.
8. Corbeau, P., Devaux, C., Kourilsky, F. & Chermann, J. C. (1990). An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Journal of Virology 64, 1459-1464.
9. Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F. & Weiss, R. A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
10. de Jong, J. J., de Ronde, A., Keulen, W., Tersmette, M. & Goudsmit, J. (1992). Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. Journal of Virology 66, 6777-6780.
11. Deng, H., Liu, R., Ellmeir, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. & Landau, N. R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
12. Devaux, C., Boucraut, J., Poirier, G., Corbeau, P., Rey, F., Benkirane, M., Perarnau, B., Kourilsky, F. & Chermann, J. C. (1990). Anti-beta-2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells. Research in Immunology 141, 357-372.
13. Dragic, T., Litwin, T., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P. & Paxton, W. A. (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR5. Nature 381, 667-673.
14. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
15. Fukudome, K., Furuse, M., Imai, T., Nishimura, M., Takagi, S., Hinuma, Y. & Yoshie, O. (1992). Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. Journal of Virology 66, 1394-1401.
16. Gorman, C. (1985). In DNA Cloning, vol. 2, A Practical Approach, p. 143. Edited by D. M. Glover. Oxford: IRL Press.
17. Hammond, C. & Helenius, A. (1994). Folding of VSV G protein: sequential interaction with BiP and calnexin. Science 266, 456-458.
18. Hildreth, J. E. K. & Orentas, R. J. (1989). Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244, 1075-1078.
19. Hohdatsu, T., Hirabayashi, H., Motokawa, K. & Koyama, H. (1996). Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtype A, subtype B and subtype D classified on the env gene V3-V5 sequence. Journal of General Virology 77, 93-100.
20. Hosie, M. J., Willett, B. J., Dunsford, T. H., Jarrett, O. & Neil, J. C. (1993). A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. Journal of Virology 67, 1667-1671.
21. Imai, T. & Yoshie, O. (1993). C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 and CD8 in T cells. Journal of Immunology 151, 6470-6481.
22. Iwamoto, R., Higashiyama, S., Mitamura, T., Taniguchi, N., Klagsburn, M. & Mekada, E. (1994). Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAF27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO Journal 13, 2322-2330.
23. Jennings, L. K., Orthofer, C. S. & Wilkinson, D. A. (1994). Platelet CD9 binds the adhesive protein fibronectin. Blood 84, A471(abstract).
24. Jordan, C. A., Watkins, B. A., Kufta, C. & Dubois-Dalq, M. (1991). Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. Journal of Virology 65, 736-742.
25. Klatzmann, D., Champagne, E., Chamaret, S., Guetard, D., Hercend, T., Gluckmann, J. C. & Montagnier, L. (1984). T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
26. Masellis-Smith, A., Jensen, G. S., Seehafer, J. G., Slupsky, J. R. & Shaw, A. R. E. (1990). Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. Journal of Immunology 144, 1607-1613.
27. Ohta, H., Tsurudome, M., Matsumura, H., Koga, Y., Morikawa, S., Kawano, M., Kusugawa, S., Komoda, H., Nishio, M. & Ito, Y. (1994). Molecular and biological characterization of fusion regulatory proteins (FRPs): anti-FRP mAbs induced HIV-mediated cell fusion via an integrin system. EMBO Journal 13, 2044-2055.
28. Oren, R., Takahashi, S., Doss, C, Levy, R. & Levy, S. (1990). TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Molecular and Cellular Biology 10, 4007.
29. Otteken, A. & Moss, B. (1996). Calareticulin interacts with newly synthesized human immunodeficiency virus envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. Journal of Biological Chemistry 271, 97-103.
30. Peterson, A. & Seed, B. (1988). Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54, 65-72.
31. Radford, K. J., Thorne, R. F. & Mersey, P. (1996). CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochemical and Biophysical Research Communications 222, 13-18.
32. Rubenstein, E., Le Naour, F., Billard, M., Prenant, M. & Boucheix, C. (1994). CD9 antigen is an accessory subunit of the VLA integrin complexes. European Journal of Immunology 24, 3005-3013.
33. Ryser, H. J.-P., Levy, E. M., Mandel, R. & DiSciullo, G. J. (1994). Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proceedings of the National Academy of Sciences, USA 91, 4559-4563.
34. Ryu, S. E., Kwong, P. D., Truneh, A., Porter, T. G., Arthos, J., Rosenberg, M., Dai, X. P., Xuong, N. H., Axel, R., Sweet, R. W. & Hendrickson, W. A. (1990). Crystal structure of an HIV binding recombinant fragment of human CD4. Nature 348, 419-426.
35. Sato, A. I., Balamuth, F. B., Ugen, K. E., Williams, W. V. & Weiner, D. B. (1994). Identification of CD7 glycoprotein as an accessory molecule in HIV-1-mediated syncytium formation and cellfree infection. Journal of Immunology 152, 5142-5152.
36. Shioda, T., Levy, J. A. & Cheng-Mayer, C. (1996). Small amino-acid changes in the V3 hypervariable region of gp120 can affect the T-cell line and macrophage tropism of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 89, 9434-9438.
37. Siebelink, K. H. J., Karlas, J. A., Rimmelzwaan, G. F., Osterhaus, A. D. M. E. & Bosch, M. L. (1995). A determinant of feline immunodeficiency virus involved in CrFK tropism. Veterinary Immunology and Immunopathology 46, 61-69.
38. Slupsky, J. R., Seehafer, J. G., Tang, S., Masellis-Smith, A. & Shaw, A. R. E. (1989). Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. Journal of Biological Chemistry 264, 12289-12293.
39. Sodora, D. L, Shpaer, E. G., Kitchell, B. E., Dow, S. W., Hoover, E. A. & Mullins, J. I. (1994). Identification of 3 feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type-1 evolutionary patterns. Journal of Virology 68, 2230-2238.
40. Sommerfelt, M. A. & Åsjo, B. (1995). Intercellular adhesion molecule 3, a candidate human immunodeficiency virus type 1 co-receptor on lymphoid and monocytoid cells. Journal of General Virology 76, 1345-1352.
41. Verschoor, E. J., Boven, L. A., Blaak, H., van Vliet, A. R. W., Horzinek, M. C. & de Ronde, A. (1995). A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. Journal of Virology 69, 4752-4757.
42. Willett, B. J. & Hosie, M. J. (1995). In Feline Immunology and Immunodeficiency, pp. 205-219. Edited by B. J. Willett & O. J. Jarrett. Oxford: Oxford University Press.
43. Willett, B. J. & Neil, J. C. (1995). cDNA cloning and eukaryotic expression of feline CD9. Molecular Immunology 32, 417-423.
44. Willett, B. J., Hosie, M. J., Dunsford, T. H., Neil, J. C. & Jarrett, O. (1991). Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS 5, 1469-1475.
45. Willett, B. J., de Parseval, A., Peri, E., Rocchi, M., Hosie, M. J., Randall, R., Klatzmann, D., Neil, J. C. & Jarrett, O. (1994a). The generation of monoclonal antibodies recognising novel epitopes by immunisation with solid matrix antigen-antibody complexes reveals a polymorphic determinant on feline CD4. Journal of Immunological Methods 176, 213-220.
46. Willett, B. J., Hosie, M. J., Jarrett, O. & Neil, J. C. (1994b). Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology 81, 228-233.
47. Yamashita, Y., Shimokata, K., Mizuno, S., Daikoku, T., Tsurumi, T. & Nishiyama, Y. (1996). Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus. Journal of Virology 70, 2237-2246.